Table: Delta-Fly Pharma -2022/23 parent forecast
Apr 21 (Reuters) -
Delta-Fly Pharma, Inc.
PARENT- ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2023 Mar 31, 2023
LATEST PREVIOUS
FORECAST FORECAST
Sales 300 mln
Operating loss 1.32 loss 1.15
Recurring loss 1.33 loss 1.15
Net loss 1.33 loss 1.15
EPS loss 234.37 yen loss 212.20 yen
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T